LT2547332T - Heterogeninės implantuojamos priemonės, skirtos vaisto pristatymui - Google Patents

Heterogeninės implantuojamos priemonės, skirtos vaisto pristatymui

Info

Publication number
LT2547332T
LT2547332T LTEP11756957.4T LT11756957T LT2547332T LT 2547332 T LT2547332 T LT 2547332T LT 11756957 T LT11756957 T LT 11756957T LT 2547332 T LT2547332 T LT 2547332T
Authority
LT
Lithuania
Prior art keywords
drug delivery
implantable devices
heterogeneous
heterogeneous implantable
devices
Prior art date
Application number
LTEP11756957.4T
Other languages
English (en)
Inventor
Rajesh Patel
Sunil BHONSLE
Original Assignee
Titan Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Titan Pharmaceuticals, Inc. filed Critical Titan Pharmaceuticals, Inc.
Publication of LT2547332T publication Critical patent/LT2547332T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
LTEP11756957.4T 2010-03-16 2011-03-16 Heterogeninės implantuojamos priemonės, skirtos vaisto pristatymui LT2547332T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31446510P 2010-03-16 2010-03-16
PCT/US2011/028727 WO2011116132A1 (en) 2010-03-16 2011-03-16 Heterogeneous implantable devices for drug delivery

Publications (1)

Publication Number Publication Date
LT2547332T true LT2547332T (lt) 2018-12-10

Family

ID=44649589

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP11756957.4T LT2547332T (lt) 2010-03-16 2011-03-16 Heterogeninės implantuojamos priemonės, skirtos vaisto pristatymui

Country Status (18)

Country Link
US (4) US10111830B2 (lt)
EP (1) EP2547332B1 (lt)
JP (2) JP5869551B2 (lt)
KR (1) KR101914119B1 (lt)
AU (1) AU2011227289B2 (lt)
CA (1) CA2792179C (lt)
CY (1) CY1120964T1 (lt)
DK (1) DK2547332T3 (lt)
ES (1) ES2699200T3 (lt)
HR (1) HRP20182014T1 (lt)
LT (1) LT2547332T (lt)
MX (1) MX354444B (lt)
PL (1) PL2547332T3 (lt)
PT (1) PT2547332T (lt)
RS (1) RS58011B1 (lt)
SG (2) SG184059A1 (lt)
SI (1) SI2547332T1 (lt)
WO (1) WO2011116132A1 (lt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2547332T (lt) 2010-03-16 2018-12-10 Titan Pharmaceuticals, Inc. Heterogeninės implantuojamos priemonės, skirtos vaisto pristatymui
JP2014530913A (ja) * 2011-10-24 2014-11-20 エンドゥ ファーマシューティカルズ ソリューションズ インコーポレイティド 移植可能ラサギリン組成物及びその治療方法
US8980298B2 (en) 2011-10-24 2015-03-17 Braeburn Pharmaceuticals Bvba Sprl Implantable tizanidine compositions and methods of treatment thereof
CN103998026B (zh) * 2011-10-24 2017-08-04 布雷本制药有限公司 可植入的药物递送组合物及其治疗方法
TW201332585A (zh) 2012-02-14 2013-08-16 Chemo Res S L 核鞘藥物遞送裝置
CN102731777B (zh) * 2012-07-06 2013-12-18 辽宁大学 聚l-谷氨酸-苄酯/聚磷酸乙酯嵌段共聚物的合成方法
WO2015184407A1 (en) * 2014-05-30 2015-12-03 Textile-Based Delivery, Inc. Drug delivery systems and related methods of use
US9669012B2 (en) 2014-10-30 2017-06-06 Textile-Based Delivery, Inc. Delivery systems
KR101693696B1 (ko) * 2015-06-12 2017-01-06 한국생산기술연구원 지혈용 다공성 구조체 및 그의 제조 방법
PT109154B (pt) * 2016-02-12 2019-11-05 Univ De Coimbra Tecnologia não-invasiva de inserto ocular para libertação controlada de fármacos
GB201603296D0 (en) 2016-02-25 2016-04-13 Ucl Business Plc Chemotactic,drug-containing polymersomes
GB201604553D0 (en) 2016-03-17 2016-05-04 Ucl Business Plc Fumarate polymersomes
CN109069526A (zh) * 2016-05-12 2018-12-21 默沙东公司 用于递送抗病毒剂的药物递送系统
JP7407595B2 (ja) * 2016-10-05 2024-01-04 タイタン ファーマシューティカルズ インコーポレイテッド バースト放出を低減する薬剤送達用の埋込可能な装置
IT201700101582A1 (it) * 2017-09-12 2019-03-12 Milano Politecnico Dispositivo per rilascio intraoculare
CN108310455B (zh) * 2018-03-20 2021-07-30 嘉兴尔云信息科技有限公司 纳米羟基磷灰石、pgs-m复合骨修复材料及其制备方法
SG11202005947RA (en) * 2018-05-24 2020-07-29 Celanese Eva Performance Polymers Corp Implantable device for sustained release of a macromolecular drug compound
US11690806B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
KR102183669B1 (ko) * 2019-03-26 2020-11-26 가톨릭대학교 산학협력단 이중 약물 방출을 위한 약물 전달체
EP4316464A1 (en) * 2021-03-29 2024-02-07 Edson Luiz Peracchi Long-lasting resorbable subcutaneous implant with prolonged release of pre-concentrated pharmacologically active substance in polymer for the treatment of hypothyroidism, and method
AU2022257118A1 (en) * 2021-04-14 2023-11-30 Titan Pharmaceuticals, Inc. Kappa-opioid receptor agonist implants for treatment of pruritus
CN113209050A (zh) * 2021-05-14 2021-08-06 浙江恒冀制药有限责任公司 基于生物相容性聚合物的长效体内皮埋或内植缓释制剂
US20230149298A1 (en) * 2021-11-17 2023-05-18 Celanese Eva Performance Polymers Llc Implantable Device for Treating an Inflammatory Eye Condition
WO2023244526A1 (en) * 2022-06-13 2023-12-21 Celanese Eva Performance Polymers Llc Monolithic implantable device for sustained release of an antibody

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379117A (en) 1961-12-05 1983-04-05 W. R. Grace & Co. Method for preparing a film of vinylidene chloride polymer
US3337665A (en) 1964-10-12 1967-08-22 Union Carbide Corp Method for the production of thermoplastic film
US3625214A (en) 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
DE2114065C2 (de) 1971-03-23 1982-08-19 Heinrich Pannenbecker Verfahren zur Herstellung von Folien aus thermoplastischen Kunststoffen mit Klebereigenschaft
US3920805A (en) 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
US3926188A (en) 1974-11-14 1975-12-16 Alza Corp Laminated drug dispenser
CA1076480A (en) * 1975-04-28 1980-04-29 John S. Kent Inert core implant pellet
US4191741A (en) 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
IT1177349B (it) 1984-11-28 1987-08-26 Prandi G & C Off Mec Testa di coestrusione circolare di piu' strati di materiali termoplastici
US4693886A (en) 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
US4883666A (en) 1987-04-29 1989-11-28 Massachusetts Institute Of Technology Controlled drug delivery system for treatment of neural disorders
US5601835A (en) 1987-04-29 1997-02-11 Massachusetts Institute Of Technology Polymeric device for controlled drug delivery to the CNS
US5114719A (en) 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
US5063018A (en) 1990-06-04 1991-11-05 Cordis Corporation Extrusion method
US5683719A (en) 1990-11-22 1997-11-04 British Technology Group Limited Controlled release compositions
EP0836473B1 (en) 1995-07-04 2001-10-31 Akzo Nobel N.V. Ring-shaped devices
US5733565A (en) * 1996-02-23 1998-03-31 The Population Council, Center For Biomedical Research Male contraceptive implant
DE19608423A1 (de) * 1996-03-05 1997-09-11 Merck Patent Gmbh Implantate mit phasenweiser Arzneistoffabgabe
US20030059471A1 (en) 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
TW586944B (en) * 1998-05-29 2004-05-11 Sumitomo Pharma Controlled release agent having a multi-layer structure
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
US6258121B1 (en) 1999-07-02 2001-07-10 Scimed Life Systems, Inc. Stent coating
US6585765B1 (en) 2000-06-29 2003-07-01 Advanced Cardiovascular Systems, Inc. Implantable device having substances impregnated therein and a method of impregnating the same
US6506437B1 (en) 2000-10-17 2003-01-14 Advanced Cardiovascular Systems, Inc. Methods of coating an implantable device having depots formed in a surface thereof
US6713081B2 (en) * 2001-03-15 2004-03-30 The United States Of America As Represented By The Department Of Health And Human Services Ocular therapeutic agent delivery devices and methods for making and using such devices
US6780424B2 (en) 2001-03-30 2004-08-24 Charles David Claude Controlled morphologies in polymer drug for release of drugs from polymer films
JP4551089B2 (ja) * 2001-10-29 2010-09-22 マサチューセッツ インスティテュート オブ テクノロジー 三次元印刷により製造されたゼロ次放出プロフィール投薬形態のような徐放投薬形態を製造するためのシステム
ES2665999T3 (es) 2002-05-31 2018-04-30 Titan Pharmaceuticals, Inc. Dispositivo polimérico implantable para la liberación sostenida de buprenorfina
CN102772357B (zh) * 2003-03-31 2014-12-31 泰坦医药品公司 用于持续释放多巴胺受体激动剂的可植入聚合物装置
EP1638536A2 (en) * 2003-05-30 2006-03-29 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of nalmefene
US8313763B2 (en) 2004-10-04 2012-11-20 Tolmar Therapeutics, Inc. Sustained delivery formulations of rapamycin compounds
KR100511618B1 (ko) 2005-01-17 2005-08-31 이경범 약물방출 조절형 다층 코팅 스텐트 및 이의 제조방법
DE102005034453A1 (de) * 2005-07-23 2007-01-25 Voith Patent Gmbh Verfahren zur Herstellung eines Papiermaschinensiebes
US20090022806A1 (en) 2006-12-22 2009-01-22 Mousa Shaker A Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof
WO2007139744A2 (en) 2006-05-23 2007-12-06 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of buprenorphine with minimal initial burst
MX2009005444A (es) 2006-11-22 2009-06-02 Organon Nv Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
CN102159257B (zh) * 2008-07-17 2015-11-25 米歇尔技术公司 药物递送医疗设备
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
WO2010105995A2 (en) * 2009-03-17 2010-09-23 Intervet International B.V. Zoo-technical drug delivery device
LT2547332T (lt) 2010-03-16 2018-12-10 Titan Pharmaceuticals, Inc. Heterogeninės implantuojamos priemonės, skirtos vaisto pristatymui

Also Published As

Publication number Publication date
PL2547332T3 (pl) 2019-07-31
HRP20182014T1 (hr) 2019-01-25
CY1120964T1 (el) 2019-12-11
KR20130038840A (ko) 2013-04-18
US20130202673A1 (en) 2013-08-08
WO2011116132A1 (en) 2011-09-22
DK2547332T3 (en) 2018-12-17
AU2011227289B2 (en) 2016-01-21
US20130195950A1 (en) 2013-08-01
RS58011B1 (sr) 2019-02-28
MX2012010611A (es) 2013-02-21
SI2547332T1 (sl) 2019-01-31
US10111830B2 (en) 2018-10-30
US20130189342A1 (en) 2013-07-25
EP2547332A1 (en) 2013-01-23
US10123971B2 (en) 2018-11-13
CA2792179C (en) 2019-04-02
EP2547332B1 (en) 2018-08-29
JP2013522314A (ja) 2013-06-13
EP2547332A4 (en) 2014-04-16
SG184059A1 (en) 2012-10-30
US20130195951A1 (en) 2013-08-01
ES2699200T3 (es) 2019-02-07
PT2547332T (pt) 2018-11-27
MX354444B (es) 2018-03-06
KR101914119B1 (ko) 2018-11-02
JP6022649B2 (ja) 2016-11-09
SG10201501964QA (en) 2015-05-28
JP2015227371A (ja) 2015-12-17
AU2011227289A1 (en) 2012-09-27
CA2792179A1 (en) 2011-09-22
JP5869551B2 (ja) 2016-02-24

Similar Documents

Publication Publication Date Title
HRP20182014T1 (hr) Heterogeni implantabilni uređaji za isporuku lijeka
EP2398531A4 (en) IMPLANTABLE DEVICES FOR DRUG DELIVERY
GB2479953B (en) Drug delivery device
HK1198139A1 (en) Drug delivery medical device
HK1179542A1 (zh) 藥物遞送裝置
EP2593039A4 (en) MEDICAL DEVICE FOR DELIVERY OF MEDICAMENT
SG10201503939SA (en) Drug delivery device
ZA201301155B (en) Ophthalmic drug delivery
ZA201201751B (en) Implantable device for controlled drug delivery
EP2544741A4 (en) DEVICE FOR DELIVERY OF MEDICAMENT
EP2533834A4 (en) APPARATUS FOR MEDICAMENT ADMINISTRATION
ZA201302588B (en) Medicament delivery device
HUE051942T2 (hu) Implantálható gyógyszerszállító készülékek genitourinális szervekhez
EP2640448A4 (en) DEVICE FOR DISTRIBUTING MEDICINE
PL3023120T3 (pl) Aparaty do podawania leków przez skórę
EP2640449A4 (en) DEVICE FOR DISTRIBUTING MEDICINE
SI2353632T1 (sl) Medicinska naprava za lokalno dajanje zdravil
IL227352A0 (en) A system for ocular administration of a drug
ZA201208185B (en) Intravaginall drug delivery device
EP2560711A4 (en) DEVICE FOR DELIVERY OF MEDICAMENT
EP2626055A4 (en) ACTIVE RELEASE DEVICE
GB201018750D0 (en) Drug delivery system